Prospective phase IIb study of AADC gene therapy in patients with aromatic L-amino acid decarboxylase (AADC) deficiency

Trial Profile

Prospective phase IIb study of AADC gene therapy in patients with aromatic L-amino acid decarboxylase (AADC) deficiency

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs AAV-hAADC (Primary)
  • Indications Inborn error amino acid metabolic disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2016 According to an Agilis Biotherapeutics media release, first patient has been treated in the study.
    • 16 Nov 2016 Status changed from not yet recruiting to recruiting, according to an Agilis Biotherapeutics media release.
    • 11 Oct 2016 According to a Agilis Biotherapeutics media release, status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top